Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Parney

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendrogliomaRobert Brown, Magdalena Zlatescu, Angelique Sijben, et al.
Journal of the National Cancer Institute|November 2, 2006
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomasXueQing Lun, Donna L Senger, Tommy Alain, et al.
Brain Pathology (Zurich, Switzerland)|February 10, 2017
Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutationRachael A Vaubel, Alissa A Caron, Seiji Yamada, et al.
Journal of Neuro-Oncology|May 3, 2022
Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI)Krissia M Rivera Perla, Oliver Y Tang, Shayla N M Durfey, et al.
Journal of Neurosurgery|October 29, 2021
IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical modelShashwat Tripathi, Tito Vivas-Buitrago, Ricardo A Domingo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyLouis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Central Nervous System Cancers, Version 1.2015Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022Craig Horbinski, Louis Burt Nabors, Jana Portnow, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendrogliomaRobert Brown, Magdalena Zlatescu, Angelique Sijben, et al.
Journal of the National Cancer Institute|November 2, 2006
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomasXueQing Lun, Donna L Senger, Tommy Alain, et al.
Brain Pathology (Zurich, Switzerland)|February 10, 2017
Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutationRachael A Vaubel, Alissa A Caron, Seiji Yamada, et al.
Journal of Neuro-Oncology|May 3, 2022
Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI)Krissia M Rivera Perla, Oliver Y Tang, Shayla N M Durfey, et al.
Journal of Neurosurgery|October 29, 2021
IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical modelShashwat Tripathi, Tito Vivas-Buitrago, Ricardo A Domingo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyLouis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Central Nervous System Cancers, Version 1.2015Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022Craig Horbinski, Louis Burt Nabors, Jana Portnow, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Pageof 2